Hot Features
Premium
Level up your trading with our powerful tools and real-time insights all in one place.
Period:
Draw Mode:
| Volume | 696,984 |
|
|||||
| News | - | ||||||
| Day High | 4.635 | Low High |
|||||
| Day Low | 4.36 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| uniQure NV | QURE | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.16 | 3.63% | 4.57 | 19:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 4.41 | 4.36 | 4.635 | 4.57 | 4.41 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 6,121 | 696,984 | US$ 4.44 | US$ 3,095,836 | - | 4.25 - 22.48 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 18:20:15 | 1 | US$ 4.58 | USD |
uniQure NV Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 217.66M | 47.84M | - | 21.9M | -308.48M | -6.45 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
uniQure NV News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical QURE Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 4.77 | 4.78 | 4.25 | 4.48 | 564,021 | -0.20 | -4.19% |
| 1 Month | 4.96 | 5.4799 | 4.25 | 4.82 | 610,062 | -0.39 | -7.86% |
| 3 Months | 5.96 | 6.87 | 4.25 | 5.33 | 953,372 | -1.39 | -23.32% |
| 6 Months | 5.55 | 8.66 | 4.25 | 6.04 | 1,092,525 | -0.98 | -17.66% |
| 1 Year | 19.33 | 22.48 | 4.25 | 8.19 | 1,059,168 | -14.76 | -76.36% |
| 3 Years | 32.32 | 38.80 | 4.25 | 15.95 | 744,620 | -27.75 | -85.86% |
| 5 Years | 56.36 | 82.49 | 4.25 | 27.60 | 655,291 | -51.79 | -91.89% |
uniQure NV Description
| uniQure NV is a gene therapy company. It develops treatment and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases. |
